NOVATO, Calif., June 13, 2024 Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare.
Dutch Bros Inc. today announced commencement of a registered underwritten public offering of its Class A common stock, par value $0.00001 per share , by certain selling stockholders associated with.
/PRNewswire/ MasTec, Inc. (NYSE: MTZ) ("MasTec") today announced the pricing of its public offering of $550,000,000 aggregate principal amount of senior.